- Increase the efficiency of prescription management.
- Improve patient adherence to medications.
- Detect and close gaps in care.
- Use advanced systems to personalize pharmacy care for patients with chronic conditions and complex therapeutic needs.
Chuck Grassley is hammering the privately held drug company on its $4,500 EpiPen competitor.
I believe this president goes full Trumpian tonight, in a style that he has made all his own.